ARAY Stock Analysis: Buy, Sell, or Hold?
ARAY - Accuray Incorporated
$0.42
0.03 (6.82%)
▲
5d:
+9.4%
30d:
-20.56%
90d:
-49.64%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: Apr 29, 2026
25d
Get Alerted When ARAY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ARAY shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: ARAY shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: ARAY is currently trading at $0.42, which is considered slightly low relative to its 30-day fair value range of $0.38 to $0.53. From a valuation perspective, the stock is trading at a discount (Forward PE: -4.0) compared to its historical average (39.3). At these levels, the market is pricing in 0% annual earnings growth.
Technical Outlook: Technically, ARAY is in a strong downtrend. Immediate support is located at $0.33, while resistance sits at $0.44. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.52 (+508.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ARAY is in a strong downtrend. Immediate support is located at $0.33, while resistance sits at $0.44. The stock is showing strong short-term momentum, up 6.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.52 (+508.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$0.38 -
$0.53
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.8%)
- BULLISH: Trading 508.0% below Wall St target ($2.52)
Fair Price Analysis
30-Day Fair Range
$0.38 -
$0.53
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.33
Resistance Level
$0.44
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.96
Wall Street Target
$2.53
(+508.0%)
Revenue Growth (YoY)
16.8%
Earnings Growth (YoY)
-96.2%
Profit Margin
-8.2%
PE vs Historical
-4.0 vs 39.3
CHEAP
Share & Embed Analysis
Last updated: April 03, 2026 4:58 AM ET
Data refreshes hourly during market hours. Next update: 5:58 AM
Data refreshes hourly during market hours. Next update: 5:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARAY showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Neve Stephen R La
BUY
20000 shares
2025-11-19
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 47 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 62 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$354 | 52 HOLD |
